Artificial Cornea and Corneal Implant Market

Market Overview:

The global artificial cornea and corneal implant market size reached USD 439.9 Million in 2023. Looking forward, IMARC Group expects the market to reach USD 778.9 Million by 2032, exhibiting a growth rate (CAGR) of 6.58% during 2024-2032. The growing prevalence of corneal infections and eye-associated disorders, rising construction of various healthcare facilities, and escalating demand for full-thickness corneal transplantation represent some of the key factors driving the market.

Artificial cornea and corneal implant refer to specific surgical procedures conducted to replace segments of the damaged cornea with healthy and unaffected corneal tissue obtained from a donor. They consist of a wide variety of medical procedures, such as penetrating and endothelial keratoplasty, which involves the transplantation of the entire corneal stem cells. They involve transplantation of implants that are hydrogels in nature and manufactured with recombinant collagen and inserted in a tiny incision made on the cornea of the patient. These procedures are primarily performed for the treatment of infectious keratitis, keratoconus, corneal ulcers, and Fuchs dystrophy diseases. Artificial cornea and corneal implant are also necessary for curing anterior corneal pathologies, such as trachoma, infectious keratitis, ocular trauma, and chemical injuries. They help improve eyesight, relieve pain, maintain the proper shape of the cornea, and treat severe infections or damage. They also assist in restoring a clear vision of patients suffering from corneal scarring and corneal diseases and enable them to perform daily activities effortlessly.

Artificial Cornea and Corneal Implant Market Trends:

At present, the increasing demand for artificial cornea and corneal implants due to the rising prevalence of corneal infections and eye-associated disorders among the masses represents one of the primary factors influencing the market positively. Besides this, the growing construction of various healthcare facilities, such as hospitals, nursing homes, and eye clinics, to provide effective treatment to patients is offering a favorable market outlook. In addition, the rising occurrence of eyesight complications among young individuals for spending prolonged hours looking at smartphones or working on computers and laptops is propelling the growth of the market. Apart from this, the increasing demand for full-thickness corneal transplantation due to the rising geriatric population worldwide is contributing to the growth of the market. Additionally, there is a rise in the adoption of minimally invasive (MI) corneal transplantation methods to avoid scarring, fasten the recovery period, and reduce the costs and duration of hospital stays. This, coupled with the increasing preference for penetrating keratoplasty procedures to treat eye-related complications in older patients, is supporting the market growth. Moreover, the rising utilization of various innovative and effective medical products, such as three-dimensional (3D) printed artificial cornea with better biocompatibility and customizability in treating corneal diseases, is strengthening the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial cornea and corneal implant market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, transplant type, disease indication and end user.

Type Insights:

• Human Cornea
• Artificial Cornea
   

The report has provided a detailed breakup and analysis of the artificial cornea and corneal implant market based on the type. This includes human cornea and artificial cornea. According to the report, human cornea represented the largest segment.

Transplant Type Insights:

• Penetrating Keratoplasty
• Endothelial Keratoplasty
• Anterior Lamellar Keratoplasty
• Keratoprosthesis
   

A detailed breakup and analysis of the artificial cornea and corneal implant market based on the transplant type has also been provided in the report. This includes penetrating keratoplasty, endothelial keratoplasty, anterior lamellar keratoplasty, and keratoprothesis. According to the report, penetrating keratoplasty accounted for the largest market share.

Disease Indication Insights:

• Fuchs' Dystrophy
• Fungal Keratitis
• Keratoconus
• Others
   

A detailed breakup and analysis of the artificial cornea and corneal implant market based on the disease indication has also been provided in the report. This includes Fuchs’ dystrophy, fungal keratitis, keratoconus, and others. According to the report, Fuchs’ dystrophy accounted for the largest market share.

End User Insights:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
   

A detailed breakup and analysis of the artificial cornea and corneal implant market based on the end user also been provided in the report. This includes hospitals, ambulatory surgical centers, and specialty clinics. According to the report, hospitals accounted for the largest market share.

Regional Insights:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (the United Kingdom, Germany, France, Italy, Spain, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for artificial cornea and corneal implant. Some of the factors driving the North America artificial cornea and corneal implant market included the aging population, rising advancements in eye care treatment procedures, improving healthcare expenditure, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global artificial cornea and corneal implant market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Advancing Sight Network,  AJL Ophthalmic S.A., Aurolab, Corneat Vision Ltd, EyeYon Medical, Florida Lions Eye Bank, Keramed Inc., L V Prasad Eye Institute, LinkoCare Life Sciences AB, Mediphacos, Presbia PLC, San Diego Eye Bank, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Report Coverage:

Key Benefits for Stakeholders:

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the artificial cornea and corneal implant market from 2018-2032.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the global artificial cornea and corneal implant market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the artificial cornea and corneal implant industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.